|

ABT-101 Clinical Trials

1 actively recruiting trial

Also known as: DBPR112

Pipeline

Phase 1/2: 1

Top Sponsors

  • Anbogen Therapeutics, Inc.1

Indications

  • HER2 Mutations1
  • Advanced Solid Tumor1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.